Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
Wednesday, August 21, 2024 1 min read
Key Takeaway: Myriad Genetics, Inc. (NASDAQ: MYGN) has announced its participation in two upcoming investor healthcare conferences. The CFO, Scott Leffler, will speak at the Wells Fargo Healthcare Conference on September 4, 2024, while the CEO, Paul J. Diaz, will present at the Morgan Stanley Healthcare Conference on September 5, 2024. Both presentations will be available via live and archived webcasts. This participation reflects Myriad's commitment to advancing genetic testing and precision medicine.
Market Sentiment Analysis
POSITIVE FACTORS
Participation in two prominent investor healthcare conferences indicates investor interest.
Leadership from Myriad Genetics will be featured, showcasing company expertise.
Webcasts of the presentations will be accessible, enhancing transparency and engagement.
Full Press Release Details
SALT LAKE CITY, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Myriad management will participate in two upcoming investor healthcare conferences.
The Wells Fargo Healthcare Conference in a fireside chat featuring Scott Leffler, Chief Financial Officer, on Sept. 4, 2024 at 1:30pm ET.
The Morgan Stanley Healthcare Conference in a fireside chat featuring Paul J. Diaz, President and CEO, on Sept. 5, 2024 at 7:00am ET.
Links to the live and archived webcasts of both presentations can be viewed at investor.myriad.com.
About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Tags
Healthcare Conference
Frequently Asked Questions
What events will Myriad Genetics participate in?
Myriad Genetics will participate in the Wells Fargo and Morgan Stanley Healthcare Conferences.
Who will represent Myriad at the Wells Fargo Conference?
Scott Leffler, Chief Financial Officer, will represent Myriad at the Wells Fargo Conference.
When is Myriad's presentation at the Morgan Stanley Conference?
Myriad's presentation at the Morgan Stanley Conference is on Sept. 5, 2024, at 7:00am ET.
Where can I find the webcasts of Myriad's presentations?
Webcasts of Myriad's presentations can be viewed at investor.myriad.com.
What does Myriad Genetics specialize in?
Myriad Genetics specializes in genetic testing and precision medicine to improve patient care.